BPC-157 was placed in Category 2 ("may present significant safety risks") in 2023, removed from that category in April 2026, and is now set for a Pharmacy Compounding Advisory Committee review in late July 2026, while CJC-1295 and Ipamorelin were placed in Category 2 back in October 2023
Plant-based diets usually fall short unless fortified
The use of peptides can vary depending on whether they have anti-aging, anti-inflammatory, immune-strengthening, or muscle-building effects
Boden, S
Hematol Am Soc Hematol Educ Program 2014:432437 Centers for Disease Control and Prevention (CDC)
At the same time, a significant section of users pushed back against the narrative, arguing that the perceived difference in appearance could easily be explained by lighting variations, harsh sunlight, camera exposure, or post-processing effects